Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Seattle Genetics, Inc. $552 Million Equity Offering

Davis Polk advised the underwriters, in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,463,415 shares of common stock, which includes 1,756,097 shares of common…

Biogen Inc. $6 Billion Senior Notes Offering

Davis Polk advised the underwriters, in connection with the SEC-registered offering by Biogen Inc. of $1.5 billion principal amount of 2.900% senior notes due 2020, $1.0 billion principal…

Davis Polk Advises MSCI on Its Acquisition of Insignis

Davis Polk is advising MSCI Inc. in connection with its acquisition of all of the assets of Insignis, Inc. Financial terms of the transaction were not disclosed. The transaction, which is…
Back to top